What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net investment in lease?

Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's net investment in lease has grown at a 8.4% compound annual growth rate (CAGR), from $6.57M to $9.81M.

Kiniksa Pharmaceuticals International, plc KNSA Net Investment in Lease

Net Investment in Lease at other companies

Ligand PharmaceuticalsLGND

——

Aurinia PharmaceuticalsAUPH

——

Agios PharmaceuticalsAGIO

——

AnaptysBio, Inc.ANAB

——

MoonLake ImmunotherapeuticsMLTX

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$214.3M+55.5%

Gross profit$193.5M+61.3%

Operating income$29.3M+121%

Net income$22.6M+165%

EPS (diluted)$0.27+145%

Balance sheet

See full

Cash & equivalents$190.0M+20.9%

Total debt$9.0M-9.0%

Total equity$605.7M+32.4%

Total assets$825.3M+37.7%

Cash flow

See full

Operating cash flow$50.2M+125%

CapEx$161.0K+62.6%

Free cash flow$50.0M+125%

Valuation

See full

Market cap$4.58B+128%

Profitability

See full

Gross margin89.3%+3.5pp

Operating margin12.4%+10.2pp

Net margin9.7%+7.6pp

FCF margin21.8%+12.2pp

Returns & leverage

See full

Return on equity13.7%+11.3pp

Debt / equity0×0.0×

Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's net investment in lease?: Kiniksa Pharmaceuticals International, plc (KNSA) reported net investment in lease of $9.33M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's net investment in lease changed year-over-year?: Kiniksa Pharmaceuticals International, plc's net investment in lease decreased by 10.7% year-over-year, from $10.45M to $9.33M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net investment in lease?: Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's net investment in lease has grown at a 8.4% compound annual growth rate (CAGR), from $6.57M to $9.81M.